Placebo to match IMP Lu AG09222
20297A
Phase 2 small_molecule active
Quick answer
Placebo to match IMP Lu AG09222 for Migraine is a Phase 2 program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- H. Lundbeck A/S
- Indication
- Migraine
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active